A Win For Aridis Pharmaceuticals, Inc.

Fri, Jun 10, 2022 at 05:30 PM
A Win For Aridis Pharmaceuticals, Inc.

Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ) shot up at $1.46, representing a gain of 29.2%. The stock appeared on our News Catalysts scanner on Fri, Jun 03, 2022 at 09:24 AM in the 'MISCELLANEOUS' category. From Thu, May 26, 2022, the stock recorded 66.67% Up Days and 30.00% Green Days

The stock spiked on Tue, Dec 21, 2021 at $4.34 with a volume of 43M+, and its share price has been moving sideways in recent weeks.

About Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ)

Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.